Skip to main content
Livermore
Livermore
ZHEN

Taysha Gene Therapies, Inc.

TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001806310

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Taysha Gene Therapies, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of TSHA: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1071119+13
Shares158.2M11.7M157.0M+10.6M (+7.2%)
Value$354.3M$26.3M$315.5M−$12.4M (−3.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Taysha Gene Therapies, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to TSHA in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.13,520,533$27.2M0.00%
Siren, L.L.C.4,879,875$9.81M0.49%
Wellington Management Group LLP463,192$931.0K0.00%
Los Angeles Capital Management LLC206,992$416.1K0.00%
Franklin Resources Inc100,795$200.6K0.00%
Mirae Asset Global ETFs Holdings Ltd.88,053$177.0K0.00%
AQR Capital Management LLC69,471$139.6K0.00%
ExodusPoint Capital Management, LP68,264$137.0K0.00%
SG Americas Securities, LLC63,984$129.0K0.00%
Intech Investment Management LLC42,094$84.6K0.00%
SEI Investments Co39,188$78.8K0.00%
Simplex Trading, LLC38,813$78.0K0.00%
EntryPoint Capital, LLC27,027$54.3K0.03%
Nebula Research & Development LLC21,737$43.7K0.01%
State Board of Administration of Florida Retirement System20,010$40.2K0.00%
Creative Planning14,118$28.4K0.00%
Mariner, LLC13,336$26.8K0.00%
HSBC Holdings PLC12,315$24.8K0.00%
Aigen Investment Management, LP11,189$22.5K0.00%
Xponance, Inc.10,869$21.8K0.00%
Mackenzie Financial Corp10,000$20.1K0.00%
Atticus Wealth Management, LLC7,425$14.9K0.00%
CIBC Private Wealth Group, LLC6,833$13.7K0.00%
Oliver Lagore Vanvalin Investment Group2,800$5.63K0.00%
Global Retirement Partners, LLC1,006$2.02K0.00%
Optiver Holding B.V.606$1.22K0.00%
Nisa Investment Advisors, LLC504$1.01K0.00%
Clear Street Markets LLC424$1.00K0.00%
Lindbrook Capital, LLC224$4500.00%
Signaturefd, LLC175$3520.00%
Sterling Capital Management LLC165$3320.00%

Sold out (18)

Institutions that held Taysha Gene Therapies, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of TSHA in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Artal Group S.A.4,354,214$9.75M
Eagle Asset Management Inc1,722,586$3.89M
Diametric Capital, LP512,361$1.15M
Millennium Management LLC340,724$763.2K
Prelude Capital Management, LLC186,591$418.0K
TD Asset Management Inc175,600$393.3K
Alpine Global Management, LLC151,483$339.3K
Virtu Financial LLC57,191$128.0K
LPL Financial LLC48,060$107.7K
Redwood Wealth Management Group, LLC46,400$103.9K
Marathon Trading Investment Management LLC45,340$101.6K
Dynamic Advisor Solutions LLC45,000$100.8K
Scientech Research LLC43,350$97.1K
Renaissance Technologies LLC41,100$92.1K
Tudor Investment Corp Et Al26,634$59.7K
Camelot Portfolios, LLC11,000$24.6K
Schechter Investment Advisors, LLC10,613$23.8K
State of Wyoming1,797$4.03K

Not filed for Q3 2024 yet (1)

Institutions that held Taysha Gene Therapies, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TSHA in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.11,742,449$26.3M